Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research
Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clinical Cancer Research 2016, 22: 1907-1913. PMID: 26888828, PMCID: PMC4861174, DOI: 10.1158/1078-0432.ccr-16-0104.Peer-Reviewed Original ResearchMeSH KeywordsAdvisory CommitteesGuidelines as TopicHumansMedical OncologyResearchRisk AssessmentTobacco UseConceptsTobacco use assessmentCancer patientsTobacco useClinical trialsTobacco dependence treatmentSecondhand smoke exposureNIH Clinical CenterClinical treatment trialsAlternative tobacco productsTobacco Use QuestionnaireTobacco use statusEffect of cessationClinical cancer researchTiming of assessmentCancer researchCessation approachesProtocol therapyStudy entrySmoke exposureTask ForceCigarette smokingAdverse outcomesTreatment trialsClinical centersDependence treatment